https://www.marketscreener.com/quote/stock/AGIOS-PHARMACEUTICALS-INC-13709228/news/Agios-Pharmaceuticals-Announces-Orphan-Drug-Designation-of-AG-348-for-Treatment-of-Pyruvate-Kinase-D-20078946/?utm_source=telegram&utm_medium=social&utm_campaign=share